Essayer OR - Gratuit
Pharma Cos Face Rough Patch With OTC Skincare Products
Mint New Delhi
|July 17, 2025
Cipla, Glenmark, Emcure are expanding with sunscreens, moisturizers and serums
India's pharmaceutical giants have a battle on their hands as they take on beauty and cosmetic startups and their influencers. Consumers are increasingly seeking out clinically-backed skincare products, according to industry experts, but drugmakers currently account for only a fraction of the overall beauty and personal care market.
Cipla Ltd, Glenmark Pharmaceuticals Ltd, and Emcure Pharmaceuticals Ltd, which have a presence in the dermatology or skin diseases segment, are expanding with sunscreens, moisturizers, and serums—products that don't need a prescription.
"There is an evident surge in cosmoderma products in India, driven by the consumer's need for a trustworthy science-backed solution that is efficacious and affordable," Shivam Puri, managing director and chief executive of Cipla Health Ltd, Cipla's consumer-focused unit, told Mint.
Cette histoire est tirée de l'édition July 17, 2025 de Mint New Delhi.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Mint New Delhi
Mint New Delhi
A plan to hunt down digital arrest crooks takes shape
To crack down on surging online financial frauds such as 'digital arrests', a parliamentary panel has recommended that banks use government-issued IDs to trace, freeze and blacklist mule accounts siphoning crores of rupees. Experts call it a crucial first step, but banks warn implementation will be difficult.
3 mins
September 26, 2025
Mint New Delhi
Why this is the toughest test yet for Indian shrimp
As if the 50% tariff imposed by the US was not debilitating enough, Indian shrimp exporters are staring at an additional anti-dumping duty of as much as 40%. How will this impact exporters and the 16 million people dependent on the seafood sector? Mint explains:
2 mins
September 26, 2025

Mint New Delhi
HI-B crisis sparks legal scramble for new HR solutions
Law firms and corporations are racing to tackle the human resources impact of the vexed H-1B matter, after US President Donald Trump's latest immigration crackdown threw India's $283 billion IT sector into turmoil.
3 mins
September 26, 2025
Mint New Delhi
CAFE-3 pitches big relief for small cars
Lower fleet-wise emissions for small cars in latest BEE draft
4 mins
September 26, 2025

Mint New Delhi
Makhana to millets, snack makers tap into mindful munching
Urban Indians' appetite for healthier snacking is growing and no food is off limits as snack-makers race to cash in on the trend.
3 mins
September 25, 2025

Mint New Delhi
What is Trump's problem with paracetamol?
US President Donald Trump has linked the use of over-the-counter painkiller Tylenol (paracetamol) by pregnant women to an increased risk of autism in children, leading to widespread alarm.
2 mins
September 25, 2025
Mint New Delhi
New highway builders may toll older parallel roads too
Highway developers winning new projects may also be allowed to operate older parallel roads and charge tolls on them, in an effort to reduce toll leakage and attract more investors.
2 mins
September 25, 2025

Mint New Delhi
Govt unwraps $8 bn outlay to buoy ports, shipping
India is setting sail on its biggest maritime bet yet, with the Union cabinet on Wednesday unveiling an incentive package of ₹69,725 crore or about $8 billion for the shipping and ports industry.
3 mins
September 25, 2025

Mint New Delhi
Large exposure rule begins to squeeze corporate lending
A six-year-old Reserve Bank of India (RBI) rule meant to keep a check on banks' lending to large corporate groups is once again causing heartburn for lenders.
3 mins
September 25, 2025

Mint New Delhi
Insolvency relief for homebuyers soon
Separating troubled projects, early house registration proposed
3 mins
September 25, 2025
Listen
Translate
Change font size